Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

OBJECTIVE: To systematically evaluate the efficacy and safety of pembrolizumab (PD-1/PD-L inhibitor) and adjuvant chemotherapy to treat NSCLC and provide evidence-based reference for clinical use. METHODS: By searching the Cochrane Library, EMBASE, PubMed, and Web of Science, according to the inclus...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Wei-wei, Zhang, Tian-wei, Wang, Bin-liang, Mao, Li-qun, Li, Xiao-bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402310/
https://www.ncbi.nlm.nih.gov/pubmed/36033563
http://dx.doi.org/10.1155/2022/9500319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402310/
https://www.ncbi.nlm.nih.gov/pubmed/36033563
http://dx.doi.org/10.1155/2022/9500319

Ejemplares similares